Kuroda, T., et al. (2023). Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo. J Antimicrob Chemother doi: 10.1093/jac/dkad027 [ACE2 and TMPRSS2-expressing HEK293T cells]
Morimoto, M., et al. (2023). Bi-allelic ATG4D variants are associated with a neurodevelopmental disorder characterized by speech and motor impairment. NPJ Genom Med doi: 10.1038/s41525-022-00343-8 [GeneHero™ HeLa Cas9-expressing stable cell line]
Osaka, T., et al. (2023). Cross-Reactivity of Antibodies in Intravenous Immunoglobulin Preparation for Protection against SARS-CoV-2. Microorganisms doi: 10.3390/microorganisms11020471 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
Koch, J., et al. (2023). Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model. Viruses doi: 10.3390/v15020363 [GFP dual-labeled HT-29 cancer cell line]
Merluza, J., et al. (2023). Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test. Microbiol Spectr doi: 10.1128/spectrum.03789-22 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
Nakata, Y., et al. (2023). Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic Acids Res doi: 10.1093/nar/gkac1238 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
